Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.40 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.37 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | GABRP | O00591 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5056923 | 0.77 | ACHE (0.41) | NOTUMIDO1KDM4ECHRNB4CHRNA3 | |
| SCHEMBL4702413 | 0.77 | NPC1 (0.41) | TAAR1ESR2NOTUMIDO1ALDH1A1 | |
| SCHEMBL3790377 | 0.77 | MAOA (0.47) | KDM4EMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL5542092 | 0.77 | NOTUM (0.44) | NOTUMIDO1 | |
| SCHEMBL5535944 | 0.75 | NPC1 (0.37) | NOTUMKDM4EALDH1A1LMNATP53 | |
| SCHEMBL39593 | 0.74 | ALDH1A1 (0.38) | MEN1KMT2AALDH1A1LMNATP53 | |
| SCHEMBL198702 | 0.71 | TAAR1 (0.68) | TAAR1ESR2NOTUMIDO1HSD17B1 | |
| SCHEMBL16605628 | 0.69 | TAAR1 (0.65) | TAAR1ESR2NOTUMIDO1HSD17B1 | |
| SCHEMBL29628985 | 0.69 | TAAR1 (0.65) | TAAR1ESR2NOTUMIDO1HSD17B1 | |
| SCHEMBL16605626 | 0.69 | TAAR1 (0.65) | TAAR1ESR2NOTUMIDO1HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115315451-B | Catalyst for olefin polymerization, method for producing catalyst for olefin polymerization, and method for producing olefin polymer using catalyst for olefin polymerization | 日本聚丙烯株式会社 | 2023-12-01 | — | — | CN | disclosed |
| US-11643485-B2 | Ethylene-based polymer, polyethylene-based resin composition and use thereof, catalyst component for olefin polymerization, olefin polymerization catalyst containing the component, and method for producing ethylene-based polymer by using the catalyst | JAPAN POLYETHYLENE CORPORATION (JP) | 2023-05-09 | — | — | US | disclosed |
| CN-115315451-A | Olefin polymerization catalyst, method for producing olefin polymerization catalyst, and method for producing olefin polymer using olefin polymerization catalyst | 日本聚丙烯株式会社 | 2022-11-08 | — | — | CN | disclosed |
| CN-108779135-B | Metallocene compound, catalyst component and catalyst for olefin polymerization comprising the same, and process for producing olefin polymer using the same | 日本聚乙烯株式会社 | 2021-09-07 | — | — | CN | disclosed |
| US-20210122856-A1 | METALLOCENE COMPOUND, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING CATALYST FOR OLEFIN POLYMERIZATION | JAPAN POLYETHYLENE CORPORATION (JP) | 2021-04-29 | — | — | US | disclosed |
| EP-3431483-B1 | METALLOCENE COMPOUND, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING CATALYST FOR OLEFIN POLYMERIZATION CATALYST | JAPAN POLYETHYLENE CORP (JP) | 2021-03-03 | — | — | EP | disclosed |
| US-10919994-B2 | Metallocene compound, catalyst component for olefin polymerization and catalyst for olefin polymerization containing the same, and method for producing olefin polymer using catalyst for olefin polymerization | JAPAN POLYETHYLENE CORPORATION (JP) | 2021-02-16 | — | — | US | disclosed |
| EP-3424937-B1 | METALLOCENE COMPOUND, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION INCLUDING SAME, CATALYST FOR OLEFIN POLYMERIZATION INCLUDING METALLOCENE COMPOUND, AND METHOD FOR PRODUCING OLEFIN POLYMER BY USING CATALYST FOR OLEFIN POLYMERIZATION | JAPAN POLYETHYLENE CORP (JP) | 2020-06-10 | — | — | EP | disclosed |
| US-10633471-B2 | Ethylene-based polymer, polyethylene-based resin composition and use thereof, catalyst component for olefin polymerization, olefin polymerization catalyst containing the component, and method for producing ethylene-based polymer by using the catalyst | JAPAN POLYETHYLENE CORPORATION (JP) | 2020-04-28 | — | — | US | disclosed |
| US-20200031965-A1 | ETHYLENE-BASED POLYMER, POLYETHYLENE-BASED RESIN COMPOSITION AND USE THEREOF, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, OLEFIN POLYMERIZATION CATALYST CONTAINING THE COMPONENT, AND METHOD FOR PRODUCING ETHYLENE-BASED POLYMER BY USING THE CATALYST | JAPAN POLYETHYLENE CORPORATION (JP) | 2020-01-30 | — | — | US | disclosed |
| CN-103582669-A | Ethylene polymer, polyethylene resin composition and use thereof, catalyst component for olefin polymerization, catalyst for olefin polymerization comprising the component, and method for producing ethylene polymer using the catalyst | JAPAN POLYETHYLENE CORP | 2014-02-12 | — | — | CN | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| CN-101255170-A | 2,3-dihydroimidazo[2,1-b]oxazole compound | OTSUKA PHARMA CO LTD (JP) | 2008-09-03 | — | — | CN | disclosed |
| CN-101172981-A | 2,3-dihydroimidazo[2,1-b]oxazole compound | OTSUKA PHARMA CO LTD (JP) | 2008-05-07 | — | — | CN | disclosed |
| CN-100366624-C | 2, 3-dihydro-6-nitroimidazo [2,1-b ] * azole compounds | OTSUKA PHARMA CO LTD (JP) | 2008-02-06 | — | — | CN | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| CN-1705670-A | 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds | OTSUKA PHARMA CO LTD (JP) | 2005-12-07 | — | — | CN | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | TAAR1 364/4885ESR2 339/4885NOTUM 3827/4885 |
| US-20210122856-A1 | METALLOCENE COMPOUND, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING CATALYST FOR OLEFIN POLYMERIZATION | COG1, CPNE4, COG4 | TAAR1 933/4885ESR2 2674/4885NOTUM 242/4885 |
| US-10919994-B2 | Metallocene compound, catalyst component for olefin polymerization and catalyst for olefin polymerization containing the same, and method for producing olefin polymer using catalyst for olefin polymerization | COG1, CPNE4, COG4 | TAAR1 933/4885ESR2 2674/4885NOTUM 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.